Document Detail

In vitro study of chondrocyte redifferentiation with lentiviral vector-mediated transgenic TGF-β3 and shRNA suppressing type I collagen in three-dimensional culture.
MedLine Citation:
PMID:  21548134     Owner:  NLM     Status:  Publisher    
Chondrocytes are the primary candidate therapeutic cells to cure cartilaginous lesions. Ideally, for transplantation, autologous chondrocytes are isolated from the patient, amplified in vitro, seeded in a scaffold and implanted back. However, significant concerns arise with chondrocyte dedifferentiation during monolayer amplification, whereby cells lose their chondrocytic phenotype by rapidly downregulating the expression of cartilage markers such as type II collagen (Col II) and aggrecan. The accompanying upregulation in type I collagen (Col I) is also problematic, as it leads to unexpected fibrosis and causes such engineered cartilage to lack the desired mechanical strength to make up joint lesions. Transforming growth factor-β3 (TGF-β3) has been proved effective in maintaining chondrocytic morphology and promoting total collagen production. In this study, we aimed to deliver the TGF-β3 gene into dedifferentiated chondrocytes with recombinant lentiviral vectors; by transgenic expression of TGF-β3, chondrocytic redifferentiation is catalysed. Simultaneously, shRNA targeting Col I was also incorporated into the vector to suppress Col I production. The results indicated that chondrocytes underwent dedifferentiation in monolayer culture in the presence or absence of transgenic TGF-β3. In three-dimensional culture, effective redifferentiation was managed in the dedifferentiated chondrocytes that were transduced with transgenic TGF-β3. The incorporation and expression of Col I-targeting shRNA were also effective in reducing Col I production in a post-transcriptional manner. Copyright © 2011 John Wiley & Sons, Ltd.
Yongchang Yao; Feng Zhang; Patricia Xiaotian Pang; Kai Su; Ruijie Zhou; Yingjun Wang; Dong-An Wang
Related Documents :
21236244 - Cytoprotective effects of growth factors: bdnf more potent than gdnf in an organotypic ...
21374124 - Primary cultures of rat hepatocytes.
21539944 - Direct deposited porous scaffolds of calcium phosphate cement with alginate for drug de...
21133724 - In a patient with biclonal waldenstrom macroglobulinemia only one clone expands in thre...
15082344 - Ascorbic acid-2-o-phosphate-6-o-palmitate protecting the human umbilical cord vein endo...
954214 - The mass spectrometric identification of dipeptides in the urine of a patient suffering...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-5
Journal Detail:
Title:  Journal of tissue engineering and regenerative medicine     Volume:  -     ISSN:  1932-7005     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-5-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101308490     Medline TA:  J Tissue Eng Regen Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 John Wiley & Sons, Ltd.
Division of Bioengineering, School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore 637457, Republic of Singapore; School of Materials Science and Engineering, South China University of Technology, Guangzhou 510641, China; Key Laboratory of Specially Functional Materials and Advanced Manufacturing Technology, South China University of Technology, Ministry of Education, Guangzhou 510641, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Tenogenic differentiation of stem cells for tendon repair-what is the current evidence?
Next Document:  Influence of the mesenchymal cell source on oral epithelial development.